BioSpace News Archive

Akero Therapeutics, Inc. today reported third quarter financial results for the period ending September 30, 2022 and provided business updates.

Tiziana Life Sciences Ltd. today announced that the Company plans to host an investor call and webcast on Thursday, November 10 2022 at 10 a.m. ET.

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced positive results from the Phase 2b RE-THINC ESRD study of fesomersen.

Elucid, Inc. has announced that the company’s technology will be featured on the program at the 2022 American Heart Association (AHA) Scientific Sessions, November 5-7, 2022 in Chicago.

Bicycle Therapeutics plc, a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology, announced that management will participate in the following investor conferences in November and December.

BeiGene today announced that the Company will participate in two upcoming investor conferences.

AnPac Bio-Medical Science Co., Ltd. announced that on October 31, 2022, the Company has been notified by the Nasdaq Hearings Panel of the Listing Qualifications Department of The Nasdaq Stock Market LLC.

Navidea Biopharmaceuticals, Inc. today announced it will host a conference call and webcast on Tuesday, November 15, 2022 at 5:00 p.m. (EST) to discuss corporate developments and financial results for the third quarter.

Rivus Pharmaceuticals Inc. today announced the company will present topline results from a Phase 2a trial evaluating the safety and efficacy of HU6, a first-in-class controlled metabolic accelerator (CMA), to address liver fat and total body fat in patients with Nonalcoholic fatty liver disease (NAFLD).

Cardiac Insight, Inc., creators of Cardea SOLO™ prescription cardiac sensors and automated electrocardiography Analysis Software, shares its perspective on the latest CMS ruling, which provides nationwide physician confidence in receiving the appropriate reimbursement for prescribing LT-ECG ambulatory diagnostic testing.